This marks Science 37’s third consecutive successful FDA inspection in less than two years. Previous inspections in March 2024 and April 2025 also resulted in NAI categorizations, with no Form 483s ...
Bangalore: Biocon has announced that its manufacturing site in Cranbury, New Jersey, has received a single observation ...